New hope for brittle bones in anorexia

NCT ID NCT04779216

Summary

This study tested whether a drug called romosozumab could help improve bone density and strength in women with anorexia nervosa, a condition that often leads to weak, fragile bones. For 12 months, 30 participants received either the drug or a placebo (inactive substance) in a blinded trial. The goal was to see if the drug could increase bone formation and improve bone structure compared to the placebo, with an additional follow-up phase using another bone medication.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANOREXIA NERVOSA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

Conditions

Explore the condition pages connected to this study.